Quantbot Technologies’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-240
Closed -$7.88K 1989
2024
Q1
$7.88K Hold
240
﹤0.01% 1466
2023
Q4
$6.43K Buy
+240
New +$9.94K ﹤0.01% 1482
2023
Q3
Sell
-925
Closed -$94.2K 2043
2023
Q2
$94.2K Buy
925
+141
+18% +$19.4K 0.01% 1193
2023
Q1
$139K Buy
784
+667
+570% +$223K 0.01% 1002
2022
Q4
$45.1K Buy
+117
New +$44.4K ﹤0.01% 1325
2022
Q2
Sell
-65
Closed -$28K 2214
2022
Q1
$28K Sell
65
-300
-82% -$123K ﹤0.01% 1315
2021
Q4
$160K Buy
+365
New +$183K 0.01% 773
2021
Q3
Sell
-61
Closed -$31K 1995
2021
Q2
$31K Sell
61
-24
-28% -$15.2K ﹤0.01% 1163
2021
Q1
$66K Buy
85
+83
+4,150% +$56.8K 0.01% 962
2020
Q4
$1K Sell
2
-53
-96% -$27.8K ﹤0.01% 1221
2020
Q3
$25K Buy
+55
New +$31.9K ﹤0.01% 992
2020
Q1
Sell
-268
Closed -$155K 1477
2019
Q4
$155K Buy
+268
New +$188K 0.02% 719
2018
Q3
Sell
-108
Closed -$74K 1601
2018
Q2
$74K Buy
+108
New +$54.9K 0.01% 929
2017
Q4
Sell
-27
Closed -$13K 1528
2017
Q3
$13K Buy
+27
New +$13.5K ﹤0.01% 1080
2017
Q2
Sell
-188
Closed -$124K 1438
2017
Q1
$124K Buy
+188
New +$100K 0.01% 749
2016
Q2
Sell
-97
Closed -$21K 1413
2016
Q1
$21K Buy
+97
New +$29K ﹤0.01% 1006

Other funds holding TVRD

Quantbot Technologies's TVRD Position: Q2 2024 in Review

Quantbot Technologies sold out of Tvardi Therapeutics (TVRD) in Q2 2024, closing a stake of 240 shares — an estimated $7.88K sold.

Quantbot Technologies first reported a position in TVRD in Q1 2016 and held it in 16 quarters. The position peaked at $160K in Q4 2021. 79 funds tracked by Wall St. Rank hold TVRD as of Q2 2024.

  • Quantbot Technologies reported no remaining Tvardi Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 240 Tvardi Therapeutics shares in Q2 2024, an estimated $7.88K.
  • Quantbot Technologies first reported a position in Tvardi Therapeutics in Q1 2016 and held it in 16 quarters.
  • Quantbot Technologies's Tvardi Therapeutics position peaked at $160K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.